4//SEC Filing
TOMSICEK MICHAEL JOHN 4
Accession 0001209191-22-057401
CIK 0001781174other
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 7:25 PM ET
Size
5.4 KB
Accession
0001209191-22-057401
Insider Transaction Report
Form 4
TOMSICEK MICHAEL JOHN
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-11-14+35,235→ 35,235 totalExercise: $12.50Exp: 2032-11-13→ Common Stock (35,235 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in 36 equal monthly installments beginning on October 12, 2022 ("Vesting Commencement Date"), such that all shares are fully vested on the third anniversary of the Vesting Commencement Date, in each case subject to the Reporting Person's continuous service through each such vesting date.
Documents
Issuer
Acrivon Therapeutics, Inc.
CIK 0001781174
Entity typeother
Related Parties
1- filerCIK 0001570392
Filing Metadata
- Form type
- 4
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 7:25 PM ET
- Size
- 5.4 KB